Abstract
Advances in Recurrent Respiratory Papillomatosis Treatment: Adjuvant Intralesional Bevacizumab’s Impact, Potential and Insights from a Case Series Study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have